Sofia Mumtaz

Building on its parent company's solid reputation, Lupin Pharma Canada Limited is committed to strengthening its branded product portfolio with the launch of additional medicines developed from its own research and manufacturing process, as well as through strategic brand acquisitions and licensing. Lupin Pharma Canada Ltd also entered the generic pharmaceutical marketplace in 2016 in the hormone therapeutic area.